Scanlon, P H <br/><br/>
The use of weighted health-related Quality of Life scores in people with diabetic macular oedema at baseline in a randomized clinical trial.  [electronic resource] 

 -  Diabetic medicine : a journal of the British Diabetic Association  Jan 2015 
 - 97-101 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1464-5491 
<br/><br/><label>Standard No.: </label>10.1111/dme.12593  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aptamers, Nucleotide--therapeutic use<br/>Cross-Sectional Studies<br/>Diabetic Retinopathy--drug therapy<br/>Female<br/>Humans<br/>Macular Edema--drug therapy<br/>Male<br/>Middle Aged<br/>Quality of Life<br/>Randomized Controlled Trials as Topic<br/>Receptors, Vascular Endothelial Growth Factor--antagonists & inhibitors<br/>Retrospective Studies<br/>Surveys and Questionnaires<br/>Treatment Outcome<br/>Visual Acuity--drug effects